News Archives - Page 9 of 90

ThursdayAug 29, 2024 12:07 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Additional Tolerability, PK Test Results

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is reporting that the tolerability and additional pharmacokinetic (“PK”) results from its human pilot study #2, GLP-1-H24-2, have been received. According to the results, absorption improvements appear to continue with DehydraTECH-processed Rybelsus(R) vs. Rybelsus tablets, even under “fed” conditions. The results also show that DehydraTECH-treated Rybelsus does absorb through a mouth-melt product format. “We were pleased to find that none of the nine people taking the DehydraTECH-processed Rybelsus swallowed as a capsule experienced any adverse events whatsoever,” the company stated in the press release. “However, of the nine human…

TuesdayAug 27, 2024 2:04 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces First Results from Second GLP-1 Human Pilot Study ‘Reinforcing DehydraTECH’s Beneficial Delivery Kinetics’

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, is announcing receipt of the first results from human pilot study #2, GLP-1-H24-2. According to the announcement, the company’s DehydraTECH(R)-processed Rybelsus(R) evidenced a trend toward higher overall absorption under fed conditions compared to Rybelsus(R) that was not processed with DehydraTECH. The DehydraTECH-processed Rybelsus(R) evidenced higher semaglutide levels in 17 of the 19 blood draws taken until the 24-hour completion of the study, averaging 18.8% higher semaglutide levels over the course of the study compared to Rybelsus(R) alone. However, the announcement noted that the differences were variable and not…

TuesdayAug 27, 2024 1:17 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today announced that CEO John Climaco will present and discuss recent corporate events at the upcoming LIVE! with Webull Corporate Connect: Virtual Biotech Investor Webinar. The presentation is scheduled for Wednesday, August 28, 2024, at 3:20 p.m. ET. To register for the live webinar, visit https://ibn.fm/JXz89 To view the full press release, visit https://ibn.fm/GfqLq About CNS Pharmaceuticals Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug…

ThursdayAug 22, 2024 1:03 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Positive 8-Week Body Weight Results from Ongoing Diabetes Animal Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, is reporting on 8-week body weight results from its ongoing animal study WEIGHT-A24-1. According to the company, this is the only study carried out anywhere in the world today to evaluate the relative performance of liraglutide processed with DehydraTECH. The results show that DehydraTECH-liraglutide is outperforming DehydraTECH-semaglutide. In humans, semaglutide has been shown in other studies to be more than twice as effective at promoting weight loss as liraglutide. Thus, the announcement noted that the continued outperformance of DehydraTECH-liraglutide compared to DehydraTECH-semaglutide is of particular interest. Additionally, the…

WednesdayAug 21, 2024 11:50 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Subsidiary to Begin Production of All-New Class 4 Commercial Truck in September

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that Bollinger Motors, its subsidiary, intends to begin production of saleable units of the Bollinger B4 Chassis Cab, an all-new Class 4 commercial EV truck, on September 16, 2024. Bollinger Motors is partnering on production with Roush Industries, which provides contract manufacturing services from its facility in Livonia, Michigan. According to the announcement, deliveries and revenue recognition of the B4 EV truck is expected to begin in October 2024. “We are already experiencing strong momentum in the market from important customers throughout the country,” commented Jim Connelly, chief…

WednesdayAug 21, 2024 11:25 am

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Three U.S. Patent Issuances

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary small molecule drug candidates, today announced its receipt of three patents granted in the U.S., strengthening its patent portfolio. The issued patents include one for its formulation and method of use in the treatment of epidermolysis bullosa and related connective tissue disorders, one for biosynthesis manufacturing processes and one for an ocular drug delivery formulation. As of August 20, 2024, InMed has a total of 13 patent families covering new chemical entities, formulations, manufacturing processes and methods of use. “We are pleased to…

TuesdayAug 20, 2024 2:54 pm

TinyGemsBreaks – ECGI Holdings Inc. (ECGI) Says Success of Allon Equestrian Apparel Line at AETA Is ‘Pivotal Moment’

ECGI Holdings (OTC: ECGI), a diversified holding company with a unique portfolio in viticulture, hospitality and luxury fashion, is reporting on the success of its Allon equestrian apparel line during the American Equestrian Trade Association (“AETA”) International trade show, which was held in Dallas. According to the company, the launch, which included a range of show coats, show shirts, breeches, safety vest covers and jewelry, “drew significant attention from key retailers.” The company called the trade show a “pivotal moment” for Allon, noting that the line continues to gain momentum in the highly competitive equestrian market. “The positive feedback we…

TuesdayAug 20, 2024 11:23 am

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Exciting INM-901 Data Providing ‘Attractive Therapeutic Approach’ in Alzheimer’s Treatment

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, today announced that recent data from preclinical studies confirms INM-901, a proprietary small molecule drug candidate, as an oral formulation that will be utilized in the company’s development programs for Alzheimer’s disease. The data shows that the INM-901 formulation can be administered orally and maintains similar drug exposure and therapeutic levels as intraperitoneal (“IP”) delivery over a 24-hour period in the brain. The announcement noted that the oral delivery method offers potential advantages such as lower treatment delivery costs. “We are…

TuesdayAug 13, 2024 1:42 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Releases Financial Results, Business Update

Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, is providing a financial and business report for the three- and nine-month period ended June 30, 2024. Highlights of the report indicate a positive stockholders’ equity of $53 million and total assets of $192 million. The report also noted, among other key milestones, that the company has secured a substantial $250 million new financing commitment; has announced a lease program for Class 1 EV cargo vans created with a focus on individuals, small businesses and fleets; and has received an order for 20 Mullen-GOs from GAMA (“GAMA”), one of its international distributors. In…

MondayAug 12, 2024 12:35 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Receives Follow-On Order from UVA

Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, has received an order for one Mullen One, a Class 1 EV cargo van, from the University of Virginia for the school’s fleet of commercial vehicles. According to the announcement, the order, which follows an earlier purchase the university made last year, will be fulfilled by Mullen’s commercial retail dealer partner, Randy Marion Automotive Group (“RMA”). The company also noted that it recently received a $7.7 million, 180-vehicle order from its dealer partner Eco Auto. The two orders represent a growing demand for Mullen's electric commercial vehicles, the announcement pointed out. The…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Breaks Categories: News